These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23285933)

  • 1. [Systematic analysis on clinical safety of Shuxuetong injection].
    Guo XF; Wen ZH; Xie YM; Liu SN; Li ZY; Chen DC
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2782-5. PubMed ID: 23285933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events to Houttuynia injection: A systematic review.
    Wang L; Cui X; Cheng L; Yuan Q; Li T; Li Y; Deng S; Shang H; Bian Z
    J Evid Based Med; 2010 Aug; 3(3):168-76. PubMed ID: 21349062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Building safety evidence body of shuxuetong injection].
    Jiang JJ; Liao X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3630-2. PubMed ID: 25532409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis and countermeasures of adverse drug reactions of traditional Chinese medicine injections in children].
    Zhang XL; Li M; Rong P; Ma R
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2807-9. PubMed ID: 23285940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of post marketing safety reevaluation of shenqi fuzheng injection].
    Ai QH; Li YY; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3633-6. PubMed ID: 25532410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Under-reporting of serious adverse drug reactions in Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions of Shuanghuanglian injection: a systematic review of public literatures.
    Wang L; Cheng L; Yuan Q; Cui X; Shang H; Zhang B; Li Y
    J Evid Based Med; 2010 Feb; 3(1):18-26. PubMed ID: 21349036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of drug safety information using large-scale adverse drug reactions database].
    Morikawa K
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2011; (129):1-26. PubMed ID: 22259840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apply association rules to analysis adverse drug reactions of shuxuening injection based on spontaneous reporting system data].
    Yang W; Xie YM; Xiang YY
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3616-20. PubMed ID: 25532406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reevaluation on adverse reaction monitoring and safety of proprietary Chinese medicines of Chongqing from 2005 to 2011].
    Yang YY; Dong Z; Zhu SB; Sun HF; Yang MP
    Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3659-63. PubMed ID: 23477159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influencing factor and mechanism analysis of adverse drug reaction in traditional Chinese medicine injection].
    Wei X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2748-51. PubMed ID: 23285926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of 103 cases with adverse drug reactions induced by sanqizongzaogan injection].
    Chen Y; Li Y; Zhu G
    Zhongguo Zhong Yao Za Zhi; 2010 Jan; 35(2):237-9. PubMed ID: 20394303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-marketing safety surveillance and re-evaluation of Xueshuantong injection.
    Li C; Xu T; Zhou P; Zhang J; Guan G; Zhang H; Ling X; Li W; Meng F; Liu G; Lv L; Yuan J; Li X; Zhu M
    BMC Complement Altern Med; 2018 Oct; 18(1):277. PubMed ID: 30326892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Literature review report on safety evaluation about Kudiezi injection].
    Liao X; Shen H; Xie YM; Zhang W; Yang W; Lv ZG
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2786-8. PubMed ID: 23285934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spontaneous reportintg system data based on shuxuetong injection adverse reactions signal warning analysis].
    Jiang JJ; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2994-7. PubMed ID: 24471318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Literature analysis of tumor treatment by Shenmai injection].
    Wang LX; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2804-6. PubMed ID: 23285939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.